Privium Fund Management B.V. 13F Holdings · Q2 2026
Privium Fund Management B.V. reported 61 securities worth $544.22M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: TSLA (17.62%), SHOP (7.76%), AMD (6.62%). Among its top 25 positions this quarter: 3 new, 8 added, 10 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TSLA | TESLA INC | $95.9M | 17.62% | 228,000 | Added |
| 2 | SHOP | SHOPIFY INC | $42.2M | 7.76% | 370,000 | Trimmed |
| 3 | AMD | ADVANCED MICRO DEVICES INC | $36.0M | 6.62% | 62,000 | Hold |
| 4 | AMZN | AMAZON COM INC | $33.4M | 6.13% | 140,000 | Added |
| 5 | IONS | IONIS PHARMACEUTICALS INC | $25.4M | 4.66% | 319,924 | Added |
| 6 | SPOT | SPOTIFY TECHNOLOGY S A | $25.3M | 4.64% | 55,000 | Trimmed |
| 7 | PLTR | PALANTIR TECHNOLOGIES INC | $23.3M | 4.29% | 200,000 | Hold |
| 8 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $19.1M | 3.51% | 234,222 | Trimmed |
| 9 | OPEN | OPENDOOR TECHNOLOGIES INC | $18.2M | 3.35% | 3.9M | New |
| 10 | LMND | LEMONADE INC | $17.6M | 3.23% | 270,259 | Added |
| 11 | NVDA | NVIDIA CORPORATION | $16.2M | 2.98% | 81,000 | Hold |
| 12 | IREN | IREN LIMITED | $15.6M | 2.86% | 340,150 | Added |
| 13 | QURE | UNIQURE NV | $15.1M | 2.78% | 328,322 | Trimmed |
| 14 | CBRS | CEREBRAS SYSTEMS INC | $13.4M | 2.46% | 60,500 | New |
| 15 | ASTS | AST SPACEMOBILE INC | $12.9M | 2.37% | 145,000 | Hold |
| 16 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $11.3M | 2.08% | 338,800 | Trimmed |
| 17 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $10.5M | 1.92% | 399,367 | Added |
| 18 | BIIB | BIOGEN INC | $10.5M | 1.92% | 48,400 | Added |
| 19 | PRQR | PROQR THRAPEUTICS N V | $10.3M | 1.89% | 5.5M | Added |
| 20 | AXSM | AXSOME THERAPEUTICS INC. | $9.8M | 1.80% | 39,944 | Trimmed |
| 21 | URGN | UROGEN PHARMA LTD | $7.7M | 1.42% | 210,000 | Trimmed |
| 22 | SPCX | SPACE EXPLORATION TECHN CORP | $6.8M | 1.26% | 40,000 | New |
| 23 | DNLI | DENALI THERAPEUTICS INC | $5.9M | 1.09% | 229,857 | Trimmed |
| 24 | VRTX | VERTEX PHARMACEUTICALS INC | $4.7M | 0.86% | 9,400 | Trimmed |
| 25 | BMRN | BIOMARIN PHARMACEUTICAL INC | $4.3M | 0.79% | 75,000 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR